MARINUS PHARMACEUTICALS INC's ticker is MRNS and the CUSIP is 56854Q101. A total of 38 filers reported holding MARINUS PHARMACEUTICALS INC in Q4 2015. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2015 | $1,476,000 | -6.1% | 193,228 | +2.5% | 0.07% | -14.6% |
| Q3 2015 | $1,572,000 | -26.9% | 188,522 | +1.6% | 0.08% | -20.4% |
| Q2 2015 | $2,151,000 | -36.2% | 185,462 | -52.1% | 0.10% | -39.1% |
| Q1 2015 | $3,372,000 | +17.3% | 387,134 | +42.3% | 0.17% | +10.5% |
| Q4 2014 | $2,875,000 | +182.1% | 272,013 | +72.7% | 0.15% | +150.8% |
| Q3 2014 | $1,019,000 | – | 157,540 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 3,977,453 | $15,194,000 | 8.96% |
| Granite Point Capital Management, L.P. | 2,638,321 | $10,078,000 | 0.98% |
| New Leaf Venture Partners, L.L.C. | 342,550 | $1,309,000 | 0.71% |
| 683 Capital Management, LLC | 1,200,000 | $4,584,000 | 0.40% |
| Virtus ETF Advisers LLC | 80,389 | $307,000 | 0.27% |
| Iguana Healthcare Management, LLC | 100,000 | $382,000 | 0.25% |
| THREE BAYS CAPITAL LP | 944,300 | $3,607,000 | 0.25% |
| Granite Point Capital Management, L.P. | 549,900 | $2,101,000 | 0.20% |
| Cormorant Asset Management, LP | 478,111 | $1,826,000 | 0.14% |
| GMT CAPITAL CORP | 2,533,798 | $9,680,000 | 0.12% |